Difference between revisions of "Template:Antithrombotics"

From blackwiki
Jump to navigation Jump to search
blackwiki>Arcadian
m (clean up - category using AWB)
blackwiki>Ronhjones
m (subst:'ing, replaced: {{•}} →  • (35) using AWB)
Line 9: Line 9:
  
 
| group1 = [[Glycoprotein IIb/IIIa inhibitors]]
 
| group1 = [[Glycoprotein IIb/IIIa inhibitors]]
|  list1 = [[Abciximab]]{{•}} [[Eptifibatide]]{{•}} [[Tirofiban]]
+
|  list1 = [[Abciximab]] •  [[Eptifibatide]] •  [[Tirofiban]]
  
 
| group2 = [[P2Y12|ADP receptor/P2Y<sub>12</sub>]] inhibitors
 
| group2 = [[P2Y12|ADP receptor/P2Y<sub>12</sub>]] inhibitors
|  list2 = ''[[thienopyridine]]s'' ([[Clopidogrel]], [[Prasugrel]], [[Ticlopidine]]){{•}} [[Ticagrelor]]<sup>†</sup>
+
|  list2 = ''[[thienopyridine]]s'' ([[Clopidogrel]], [[Prasugrel]], [[Ticlopidine]])&#160;&#8226;  [[Ticagrelor]]<sup>†</sup>
  
 
| group3 = [[Prostaglandin analogue]] ([[Prostacyclin|PGI2]])
 
| group3 = [[Prostaglandin analogue]] ([[Prostacyclin|PGI2]])
|  list3 = [[Beraprost]]{{•}} [[Prostacyclin]]{{•}} [[Iloprost]]{{•}} [[Treprostinil]]
+
|  list3 = [[Beraprost]]&#160;&#8226;  [[Prostacyclin]]&#160;&#8226;  [[Iloprost]]&#160;&#8226;  [[Treprostinil]]
  
 
| group4 = [[Mechanism of action of aspirin|COX inhibitors]]
 
| group4 = [[Mechanism of action of aspirin|COX inhibitors]]
|  list4 = [[Aspirin|Acetylsalicylic acid/Aspirin]]<sup>#</sup>{{•}} [[Aloxiprin]]{{•}} [[Carbasalate calcium]]{{•}} [[Indobufen]]{{•}} [[Triflusal]]
+
|  list4 = [[Aspirin|Acetylsalicylic acid/Aspirin]]<sup>#</sup>&#160;&#8226;  [[Aloxiprin]]&#160;&#8226;  [[Carbasalate calcium]]&#160;&#8226;  [[Indobufen]]&#160;&#8226;  [[Triflusal]]
  
 
| group5 = [[Thromboxane]] inhibitors
 
| group5 = [[Thromboxane]] inhibitors
|  list5 = ''[[thromboxane synthase]] inhibitors'' ([[Dipyridamole]], [[Picotamide]]){{•}} ''[[Thromboxane receptor antagonist|receptor antagonist]]'' ([[Terutroban]]<sup>†</sup>)
+
|  list5 = ''[[thromboxane synthase]] inhibitors'' ([[Dipyridamole]], [[Picotamide]])&#160;&#8226;  ''[[Thromboxane receptor antagonist|receptor antagonist]]'' ([[Terutroban]]<sup>†</sup>)
  
 
| group6 = [[Phosphodiesterase inhibitor]]s
 
| group6 = [[Phosphodiesterase inhibitor]]s
|  list6 = [[Cilostazol]]{{•}} [[Dipyridamole]]{{•}} [[Triflusal]]
+
|  list6 = [[Cilostazol]]&#160;&#8226;  [[Dipyridamole]]&#160;&#8226;  [[Triflusal]]
  
 
| group7 = Other  
 
| group7 = Other  
|  list7 = [[Cloricromen]]{{•}} [[Ditazole]]
+
|  list7 = [[Cloricromen]]&#160;&#8226;  [[Ditazole]]
  
 
}}
 
}}
Line 36: Line 36:
  
 
   | group1 = [[Vitamin K antagonist]]s<br />(inhibit [[Thrombin|II]], [[Factor VII|VII]], [[Factor IX|IX]], [[Factor X|X]])
 
   | group1 = [[Vitamin K antagonist]]s<br />(inhibit [[Thrombin|II]], [[Factor VII|VII]], [[Factor IX|IX]], [[Factor X|X]])
   |  list1 = ''[[coumarin]]s:'' [[Acenocoumarol]]{{•}} [[Coumatetralyl]]{{•}} [[Dicoumarol]]{{•}} [[Ethyl biscoumacetate]]{{•}} [[Phenprocoumon]]{{•}} [[Warfarin]]
+
   |  list1 = ''[[coumarin]]s:'' [[Acenocoumarol]]&#160;&#8226;  [[Coumatetralyl]]&#160;&#8226;  [[Dicoumarol]]&#160;&#8226;  [[Ethyl biscoumacetate]]&#160;&#8226;  [[Phenprocoumon]]&#160;&#8226;  [[Warfarin]]
  
''[[1,3-Indandione]]s:'' [[Clorindione]]{{•}} [[Diphenadione]]{{•}} [[Phenindione]]
+
''[[1,3-Indandione]]s:'' [[Clorindione]]&#160;&#8226;  [[Diphenadione]]&#160;&#8226;  [[Phenindione]]
  
 
''other:'' [[Tioclomarol]]  
 
''other:'' [[Tioclomarol]]  
Line 61: Line 61:
 
|  list6 = ''[[Direct_thrombin_inhibitor#Bivalent|bivalent]]:'' [[Hirudin]] ([[Bivalirudin]], [[Lepirudin]], [[Desirudin]])<br />
 
|  list6 = ''[[Direct_thrombin_inhibitor#Bivalent|bivalent]]:'' [[Hirudin]] ([[Bivalirudin]], [[Lepirudin]], [[Desirudin]])<br />
  
''[[Direct_thrombin_inhibitor#Univalent|univalent]]:'' [[Argatroban]]{{•}} [[Dabigatran]]{{•}} [[Melagatran]]<sup>‡</sup>{{•}} [[Ximelagatran]]<sup>‡</sup>
+
''[[Direct_thrombin_inhibitor#Univalent|univalent]]:'' [[Argatroban]]&#160;&#8226;  [[Dabigatran]]&#160;&#8226;  [[Melagatran]]<sup>‡</sup>&#160;&#8226;  [[Ximelagatran]]<sup>‡</sup>
  
 
| group8 = Other  
 
| group8 = Other  
|  list8 = [[REG1<!--instantly reversible aptamer based direct FIXa inhibitor in IIb trials -->]]{{•}}[[Defibrotide]]{{•}} [[Ramatroban]]{{•}} [[Antithrombin|Antithrombin III]]{{•}} [[Protein C]] ([[Drotrecogin alfa]])
+
|  list8 = [[REG1<!--instantly reversible aptamer based direct FIXa inhibitor in IIb trials -->]]&#160;&#8226; [[Defibrotide]]&#160;&#8226;  [[Ramatroban]]&#160;&#8226;  [[Antithrombin|Antithrombin III]]&#160;&#8226;  [[Protein C]] ([[Drotrecogin alfa]])
  
 
}}
 
}}
  
 
| group5 = [[Thrombolytic drug]]s/<br />[[fibrinolytic]]s
 
| group5 = [[Thrombolytic drug]]s/<br />[[fibrinolytic]]s
|  list5 = ''[[plasminogen activator]]s:'' ''[[recombinant tissue plasminogen activators|r-tPA]]'' ([[Tissue plasminogen activator|Alteplase]], [[Reteplase]], [[Tenecteplase]]){{•}} ''UPA'' ([[Urokinase]], [[Saruplase]]){{•}} [[Streptokinase]]<sup>#</sup>{{•}} [[Anistreplase]]{{•}} [[Monteplase]]
+
|  list5 = ''[[plasminogen activator]]s:'' ''[[recombinant tissue plasminogen activators|r-tPA]]'' ([[Tissue plasminogen activator|Alteplase]], [[Reteplase]], [[Tenecteplase]])&#160;&#8226;  ''UPA'' ([[Urokinase]], [[Saruplase]])&#160;&#8226;  [[Streptokinase]]<sup>#</sup>&#160;&#8226;  [[Anistreplase]]&#160;&#8226;  [[Monteplase]]
  
''other [[serine endopeptidase]]s:'' [[Ancrod]]{{•}} [[Fibrinolysin]]
+
''other [[serine endopeptidase]]s:'' [[Ancrod]]&#160;&#8226;  [[Fibrinolysin]]
  
 
[[Brinase]]
 
[[Brinase]]
Line 77: Line 77:
  
 
| group8 = [[Anticoagulant#Anticoagulants outside the body|Non-medicinal]]
 
| group8 = [[Anticoagulant#Anticoagulants outside the body|Non-medicinal]]
|  list8 = [[Citrate]]{{•}} [[EDTA]]{{•}} [[Oxalate]]
+
|  list8 = [[Citrate]]&#160;&#8226;  [[EDTA]]&#160;&#8226;  [[Oxalate]]
  
 
| group9 =  
 
| group9 =  

Revision as of 22:46, 30 December 2010